Executive functioning and quality of life in acromegaly

References

• MelmedSAcromegaly pathogenesis and treatmentJ Clin Invest2009119113189320219884662
   PubMed Web of Science ®Google Scholar
• Martín-RodríguezJFMadrazo-AtutxaAVenegas-MorenoENeurocognitive function in acromegaly after surgical resection of GH-secreting adenoma versus naïve acromegalyPLoS One201384e6004123593161
   PubMed Web of Science ®Google Scholar
• NiculescuDABaciuIFCapatinaCAcromegaly treatment in Romania. How close are we to disease control?Endokrynol Pol201768551952328879646
   PubMed Web of Science ®Google Scholar
• SieversCSämannPGDoseTMacroscopic brain architecture changes and white matter pathology in acromegaly: a clinicoradiological studyPituitary200912317718518836838
   PubMed Web of Science ®Google Scholar
• ÅbergNDBryweKGIsgaardJAspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brainScientificWorldJournal20066538016432628
   PubMed Web of Science ®Google Scholar
• HallbergMNybergFGrowth hormone receptors in the brain and their potential as therapeutic targets in central nervous system disordersOpen Endocrinol J2012612733
   Google Scholar
• LaiZRoosPZhaiOAge-related reduction of human growth hormone-binding sites in the human brainBrain Res199362122602668242339
   PubMed Web of Science ®Google Scholar
• PereiraAMNeuropsychological functioning in acromegaly: towards identification of modifiable factors to improve long-term care after remissionEndocrine201550352352526349939
   PubMed Web of Science ®Google Scholar
• SuchyYExecutive functioning: overview, assessment, and research issues for non-neuropsychologistsAnn Behav Med200937210611619455377
   PubMed Web of Science ®Google Scholar
• SalthouseTAWhat cognitive abilities are involved in trail-making performance?Intelligence201139422223221789028
   PubMed Web of Science ®Google Scholar
• BowieCRHarveyPDAdministration and interpretation of the trail making testNat Protoc2006152277228117406468
   PubMed Web of Science ®Google Scholar
• HeflinLHLaluzVJangJKetelleRMillerBLKramerJHLet’s inhibit our excitement: the relationships between Stroop, behavioral disinhibition, and the frontal lobesNeuropsychology201125565566521574716
   PubMed Web of Science ®Google Scholar
• NybergFGrowth hormone in the brain: characteristics of specific brain targets for the hormone and their functional significanceFront Neuroendocrinol200021433034811013068
   PubMed Web of Science ®Google Scholar
• DeijenJBArwertLIDrentMLThe GH/IGF-I Axis and cognitive changes across a 4-year period in healthy adultsISRN Endocrinol2011201116
   Google Scholar
• Al-DelaimyWKvon MuhlenDBarrett-ConnorEInsulinlike growth factor-1, insulinlike growth factor binding protein-1, and cognitive function in older men and womenJ Am Geriatr Soc20095781441144619515112
   PubMed Web of Science ®Google Scholar
• BurmanPHettaJWideLMånssonJEEkmanRKarlssonFAGrowth hormone treatment affects brain neurotransmitters and thyroxine [see comment]Clin Endocrinol1996443319324
   Web of Science ®Google Scholar
• CrespoIWebbSMPerception of health and cognitive dysfunction in acromegaly patientsEndocrine201446336536724664361
   PubMed Web of Science ®Google Scholar
• SzcześniakDMJawiarczyk-PrzybyłowskaAMatusiakŁIs there any difference in acromegaly and other chronic disease in quality of life and psychiatric morbidity?Endokrynol Pol201768552453228879648
   PubMed Web of Science ®Google Scholar
• PsarasTHoneggerJGallwitzBMilianMAre there gender-specific differences concerning quality of life in treated acromegalic patients?Exp Clin Endocrinol Diabetes2011119530030521031340
   PubMed Web of Science ®Google Scholar
• T’sjoenGBexMMaiterDVelkeniersBAbsRHealth-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegalyEur J Endocrinol2007157441141717893254
   PubMed Web of Science ®Google Scholar
• MattaMPCoutureECazalsLVezzosiDBennetACaronPImpaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearanceEur J Endocrinol2008158330531018299462
   PubMed Web of Science ®Google Scholar
• WebbSMBadiaXSurinachNLSpanish AcroQol Study GroupValidity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective studyEur J Endocrinol2006155226927716868140
   PubMed Web of Science ®Google Scholar
• WebbSMBadiaXQuality of life in growth hormone deficiency and acromegalyEndocrinol Metab Clin North Am200736122123217336742
   PubMed Web of Science ®Google Scholar
• KunzlerLSNavesLACasulariLACognitive-behavioral therapy improves the quality of life of patients with acromegalyPituitary201821332333329644512
   PubMed Web of Science ®Google Scholar
• Muñoz Ladrón de GuevaraCFernández-SerranoMJReyes del PasoGADuschekSExecutive function impairments in fibromyalgia syndrome: relevance of clinical variables and body mass indexPLoS One2018134e019632929694417
   PubMed Web of Science ®Google Scholar
• PerezKMPatelNJLordJHExecutive function in adolescents with Type 1 diabetes: relationship to adherence, glycemic control, and psychosocial outcomesJ Pediatr Psychol201742663664628008003
   PubMed Web of Science ®Google Scholar
• SieversCSämannPGPfisterHCognitive function in acromegaly: description and brain volumetric correlatesPituitary201215335035721735089
   PubMed Web of Science ®Google Scholar
• Leon-CarrionJMartin-RodriguezJFMadrazo-AtutxaAEvidence of cognitive and neurophysiological impairment in patients with untreated naive acromegalyJ Clin Endocrinol Metab20109594367437920554710
   PubMed Web of Science ®Google Scholar
• TiemensmaJBiermaszNRvan der MastRCIncreased psychopathology and maladaptive personality traits, but normal cognitive functioning, in patients after long-term cure of acromegalyJ Clin Endocrinol Metab20109512365367
   Web of Science ®Google Scholar
• BrummelmanPKoertsJDullaartRPEffects of previous growth hormone excess and current medical treatment for acromegaly on cognitionEur J Clin Invest201242121317132423083406
   PubMed Web of Science ®Google Scholar
• YedinakCGFleseriuMSelf-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and nonfunctional pituitary adenoma: a pilot studyEndocrine201446358559324282035
   PubMed Web of Science ®Google Scholar
• TanriverdiFYapislarHKaracaZUnluhizarciKSuerCKelestimurFEvaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegalyGrowth Horm IGF Res2009191243018567522
   PubMed Web of Science ®Google Scholar